​

Funding Round

Post-IPO Debt - Mithra Pharmaceuticals SA

Post-IPO Debt - Mithra Pharmaceuticals SA

Investment Firm

Overview

Mithra Pharmaceuticals SA specializes in the development of women's health care products.

Announced Date

Feb 05, 2024

Funding Type

Post Ipo Debt

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

Highbridge Capital Management

Highbridge Capital Management

Highbridge Capital Management is a convertible_note and debt and early_stage_venture and late_stage_venture and post_ipo and private_equity firm.

Participant Investors

2

Investor Name
Participant InvestorWhitebox Advisors
Participant InvestorHighbridge Capital Management

Round Details and Background

Mithra Pharmaceuticals SA raised $21000000 on 2024-02-05 in Post-IPO Debt

Mithra Pharmaceuticals SA specializes in the development of women's health care products.

Company Funding History

6

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jun 21, 2022
Post-IPO Equity - Mithra Pharmaceuticals SA
-24.7M
Aug 08, 2022
Post-IPO Debt - Mithra Pharmaceuticals SA
2-89.2M
Aug 24, 2023
Post-IPO Equity - Mithra Pharmaceuticals SA
1-21.6M
Feb 05, 2024
Post-IPO Debt - Mithra Pharmaceuticals SA
2-21.0M

Recent Activity

There is no recent news or activity for this profile.